

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.64188805 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.64188805 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.40311707 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.40311707 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.24590192 |
| 6 | * COPII vesicle coating (GO:0048208) | 5.89641488 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.88190999 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.88190999 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.88190999 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.81137644 |
| 11 | Golgi transport vesicle coating (GO:0048200) | 5.68412078 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 5.68412078 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.58360875 |
| 14 | nuclear pore complex assembly (GO:0051292) | 5.52459274 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.36445344 |
| 16 | urea cycle (GO:0000050) | 5.22313097 |
| 17 | urea metabolic process (GO:0019627) | 5.22313097 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.20956739 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.19064063 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.17668311 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.12891748 |
| 22 | protein carboxylation (GO:0018214) | 5.12891748 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.99359600 |
| 24 | intestinal cholesterol absorption (GO:0030299) | 4.98450527 |
| 25 | acylglycerol homeostasis (GO:0055090) | 4.96700460 |
| 26 | triglyceride homeostasis (GO:0070328) | 4.96700460 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.83382517 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.83232271 |
| 29 | bile acid metabolic process (GO:0008206) | 4.79579285 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.76403053 |
| 31 | complement activation, alternative pathway (GO:0006957) | 4.76143416 |
| 32 | regulation of fibrinolysis (GO:0051917) | 4.73648987 |
| 33 | alpha-linolenic acid metabolic process (GO:0036109) | 4.72509329 |
| 34 | cysteine metabolic process (GO:0006534) | 4.68281857 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.64812860 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.62885460 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.61457791 |
| 38 | cholesterol efflux (GO:0033344) | 4.57491980 |
| 39 | nuclear pore organization (GO:0006999) | 4.56503962 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.52496716 |
| 41 | regulation of complement activation (GO:0030449) | 4.51502168 |
| 42 | cellular glucuronidation (GO:0052695) | 4.50921158 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.49308564 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.49206915 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.48313695 |
| 46 | phospholipid efflux (GO:0033700) | 4.46555706 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.40250743 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.32487306 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.32487306 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.32487306 |
| 51 | bile acid and bile salt transport (GO:0015721) | 4.30224483 |
| 52 | plasma lipoprotein particle assembly (GO:0034377) | 4.27314832 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.23665750 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.18691956 |
| 55 | regulation of bile acid biosynthetic process (GO:0070857) | 4.17493817 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 4.16592913 |
| 57 | amine catabolic process (GO:0009310) | 4.16592913 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.13076642 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.09251755 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.09251755 |
| 61 | cytolysis (GO:0019835) | 4.08508759 |
| 62 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.07481578 |
| 63 | proline biosynthetic process (GO:0006561) | 4.05723049 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 4.05486213 |
| 65 | * vesicle coating (GO:0006901) | 4.05458722 |
| 66 | glucuronate metabolic process (GO:0019585) | 4.01473045 |
| 67 | uronic acid metabolic process (GO:0006063) | 4.01473045 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 3.98392631 |
| 69 | pore complex assembly (GO:0046931) | 3.95898419 |
| 70 | cell adhesion mediated by integrin (GO:0033627) | 3.93215464 |
| 71 | ER overload response (GO:0006983) | 3.93100571 |
| 72 | cholesterol homeostasis (GO:0042632) | 3.88238479 |
| 73 | embryonic process involved in female pregnancy (GO:0060136) | 3.87849821 |
| 74 | drug catabolic process (GO:0042737) | 3.86637399 |
| 75 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.85677225 |
| 76 | proline metabolic process (GO:0006560) | 3.84385633 |
| 77 | sterol homeostasis (GO:0055092) | 3.82899217 |
| 78 | lipoprotein metabolic process (GO:0042157) | 3.80509523 |
| 79 | coenzyme catabolic process (GO:0009109) | 3.79333267 |
| 80 | alkaloid metabolic process (GO:0009820) | 3.76864699 |
| 81 | protein-lipid complex assembly (GO:0065005) | 3.75554079 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73207947 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73207947 |
| 84 | phospholipid homeostasis (GO:0055091) | 3.72537175 |
| 85 | cellular amino acid catabolic process (GO:0009063) | 3.72287345 |
| 86 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.69899077 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 3.69713494 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.69316718 |
| 89 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.68874202 |
| 90 | fibrinolysis (GO:0042730) | 3.68712564 |
| 91 | skin morphogenesis (GO:0043589) | 3.68036614 |
| 92 | lysine catabolic process (GO:0006554) | 3.66467181 |
| 93 | lysine metabolic process (GO:0006553) | 3.66467181 |
| 94 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.65368403 |
| 95 | glycine metabolic process (GO:0006544) | 3.64720287 |
| 96 | NAD biosynthetic process (GO:0009435) | 3.61569818 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 3.59293038 |
| 98 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.58962161 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 3.57286190 |
| 100 | epoxygenase P450 pathway (GO:0019373) | 3.52732323 |
| 101 | intestinal absorption (GO:0050892) | 3.52625991 |
| 102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.47624777 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.47603722 |
| 104 | heme transport (GO:0015886) | 3.45469984 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.44403894 |
| 106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.41747181 |
| 107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.41747181 |
| 108 | glutamate metabolic process (GO:0006536) | 3.41479630 |
| 109 | complement activation (GO:0006956) | 3.35695358 |
| 110 | protein-lipid complex subunit organization (GO:0071825) | 3.33626910 |
| 111 | cofactor catabolic process (GO:0051187) | 3.32691060 |
| 112 | arginine metabolic process (GO:0006525) | 3.32139335 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 3.29950983 |
| 114 | cellular modified amino acid catabolic process (GO:0042219) | 3.29600884 |
| 115 | protein activation cascade (GO:0072376) | 3.29170248 |
| 116 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.21929928 |
| 117 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.17702673 |
| 118 | positive regulation of nuclease activity (GO:0032075) | 3.14523442 |
| 119 | regulation of RNA export from nucleus (GO:0046831) | 3.11878076 |
| 120 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.04912353 |
| 121 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.00362931 |
| 122 | ER-nucleus signaling pathway (GO:0006984) | 3.00059682 |
| 123 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.99523964 |
| 124 | regulation of nuclease activity (GO:0032069) | 2.98685449 |
| 125 | desmosome organization (GO:0002934) | 2.98464409 |
| 126 | negative regulation of fatty acid transport (GO:2000192) | 2.96340172 |
| 127 | negative regulation of lipase activity (GO:0060192) | 2.91791852 |
| 128 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.87770520 |
| 129 | positive regulation of extracellular matrix organization (GO:1903055) | 2.87291950 |
| 130 | cellular response to unfolded protein (GO:0034620) | 2.86477651 |
| 131 | regulation of plasminogen activation (GO:0010755) | 2.85897617 |
| 132 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.85079498 |
| 133 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.83349359 |
| 134 | regulation of early endosome to late endosome transport (GO:2000641) | 2.73943559 |
| 135 | protein retention in ER lumen (GO:0006621) | 2.69986872 |
| 136 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.67897711 |
| 137 | mitotic sister chromatid cohesion (GO:0007064) | 2.65035230 |
| 138 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.62749741 |
| 139 | collagen fibril organization (GO:0030199) | 2.60825151 |
| 140 | negative regulation of lipid transport (GO:0032369) | 2.57884842 |
| 141 | lipoprotein transport (GO:0042953) | 2.57295487 |
| 142 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.55560284 |
| 143 | chondrocyte development (GO:0002063) | 2.54735110 |
| 144 | cellular response to topologically incorrect protein (GO:0035967) | 2.53944225 |
| 145 | midgut development (GO:0007494) | 2.52265225 |
| 146 | protein hydroxylation (GO:0018126) | 2.49292781 |
| 147 | negative regulation of DNA repair (GO:0045738) | 2.48425582 |
| 148 | regulation of transforming growth factor beta production (GO:0071634) | 2.47970180 |
| 149 | chondrocyte proliferation (GO:0035988) | 2.47957055 |
| 150 | * regulation of cholesterol homeostasis (GO:2000188) | 2.47906018 |
| 151 | hypotonic response (GO:0006971) | 2.45354509 |
| 152 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.43160837 |
| 153 | mitotic chromosome condensation (GO:0007076) | 2.41358464 |
| 154 | * protein N-linked glycosylation via asparagine (GO:0018279) | 2.41064370 |
| 155 | anterior/posterior axis specification, embryo (GO:0008595) | 2.40643518 |
| 156 | mRNA modification (GO:0016556) | 2.40549323 |
| 157 | positive regulation of blood coagulation (GO:0030194) | 2.40495476 |
| 158 | positive regulation of hemostasis (GO:1900048) | 2.40495476 |
| 159 | acrosome assembly (GO:0001675) | 2.39315694 |
| 160 | regulation of vitamin metabolic process (GO:0030656) | 2.39149837 |
| 161 | * peptidyl-asparagine modification (GO:0018196) | 2.38687934 |
| 162 | endodermal cell differentiation (GO:0035987) | 2.38629568 |
| 163 | positive regulation of coagulation (GO:0050820) | 2.38055209 |
| 164 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.35200362 |
| 165 | peptidyl-proline hydroxylation (GO:0019511) | 2.34661863 |
| 166 | negative regulation of protein activation cascade (GO:2000258) | 2.33210982 |
| 167 | regulation of metalloenzyme activity (GO:0048552) | 2.32435942 |
| 168 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.31359242 |
| 169 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.29555556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.96319085 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.73497047 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.48762613 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.22801685 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21798698 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.85469557 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.68349743 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.18588638 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.83239906 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.67254590 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.01422459 |
| 12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.98972031 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.94954205 |
| 14 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.80011877 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.76465942 |
| 16 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.71533531 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.69126574 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34158765 |
| 19 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.26507956 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15968587 |
| 21 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.12749774 |
| 22 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.97597376 |
| 23 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.97597376 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85083789 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.81460131 |
| 26 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.77450917 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73711719 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72694581 |
| 29 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.69655999 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.65302740 |
| 31 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65212915 |
| 32 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.65212546 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.59954860 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59746524 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59254644 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58819980 |
| 37 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.53113520 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51304794 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50953822 |
| 40 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50450419 |
| 41 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.49722009 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46188265 |
| 43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45072282 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40839534 |
| 45 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.40687789 |
| 46 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40072230 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39575924 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36137493 |
| 49 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.36080870 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35435839 |
| 51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34057462 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33516720 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24977959 |
| 54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24879767 |
| 55 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24493775 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23839028 |
| 57 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.22832385 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22048206 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21061028 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19708675 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18067632 |
| 62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16532335 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16243250 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14400656 |
| 65 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12116633 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11356769 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11310074 |
| 68 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11258579 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10343014 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10262033 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10125109 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09228023 |
| 73 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.09129557 |
| 74 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09096246 |
| 75 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08253253 |
| 76 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06798434 |
| 77 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05189799 |
| 78 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04861587 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03121924 |
| 80 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.02971019 |
| 81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02577310 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01451682 |
| 83 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01444685 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98443656 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97846745 |
| 86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97214574 |
| 87 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.96139730 |
| 88 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95861781 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95673396 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95500256 |
| 91 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94121951 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93696868 |
| 93 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93329715 |
| 94 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.85806749 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85651613 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85546066 |
| 97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83838283 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80658050 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77580369 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77260141 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76681381 |
| 102 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.76637204 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76298353 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75583855 |
| 105 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75369324 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74202213 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74202213 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.73520350 |
| 109 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72895483 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72451741 |
| 111 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71174829 |
| 112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70792652 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70606659 |
| 114 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.70420011 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70093364 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69970371 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.68334512 |
| 118 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.68247055 |
| 119 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.68097802 |
| 120 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.68097802 |
| 121 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.68097802 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67882364 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66312775 |
| 124 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.65299577 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.64516430 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.63955079 |
| 127 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.62607667 |
| 128 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.62398191 |
| 129 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.61524291 |
| 130 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.61340220 |
| 131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60776397 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.60061896 |
| 133 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.59302092 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.59217651 |
| 135 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57407512 |
| 136 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.57266735 |
| 137 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.57218183 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.57132351 |
| 139 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.56901489 |
| 140 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.56300994 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55619575 |
| 142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.54793625 |
| 143 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.54344173 |
| 144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54334693 |
| 145 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.54279185 |
| 146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.53210253 |
| 147 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52270568 |
| 148 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.51729182 |
| 149 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.51673534 |
| 150 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.51327520 |
| 151 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48776097 |
| 152 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.48640931 |
| 153 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.48606513 |
| 154 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48152010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.77574815 |
| 2 | MP0005360_urolithiasis | 7.13271416 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.34341627 |
| 4 | MP0005365_abnormal_bile_salt | 6.20074695 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.66379409 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.42950641 |
| 7 | MP0003252_abnormal_bile_duct | 3.76905546 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.58806072 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.11818054 |
| 10 | MP0004272_abnormal_basement_membrane | 2.88683066 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.81000730 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.78579689 |
| 13 | MP0003950_abnormal_plasma_membrane | 2.75783713 |
| 14 | MP0009840_abnormal_foam_cell | 2.73996059 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.61265903 |
| 16 | MP0003195_calcinosis | 2.55404157 |
| 17 | MP0005275_abnormal_skin_tensile | 2.50940813 |
| 18 | MP0005332_abnormal_amino_acid | 2.47861929 |
| 19 | MP0005083_abnormal_biliary_tract | 2.35360194 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.25970286 |
| 21 | MP0003941_abnormal_skin_development | 2.22096002 |
| 22 | MP0000609_abnormal_liver_physiology | 2.08163259 |
| 23 | MP0003091_abnormal_cell_migration | 1.95128158 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.91513101 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.88874619 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.87932926 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.87097902 |
| 28 | MP0006054_spinal_hemorrhage | 1.80635979 |
| 29 | MP0009697_abnormal_copulation | 1.71900475 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.67272256 |
| 31 | MP0003868_abnormal_feces_composition | 1.66579030 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.63552198 |
| 33 | MP0001764_abnormal_homeostasis | 1.62132408 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.60413122 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.43138740 |
| 36 | MP0005409_darkened_coat_color | 1.42592170 |
| 37 | MP0004233_abnormal_muscle_weight | 1.35125216 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.28589684 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.28471274 |
| 40 | MP0002086_abnormal_extraembryonic_tissu | 1.24334514 |
| 41 | MP0001730_embryonic_growth_arrest | 1.24105399 |
| 42 | MP0010307_abnormal_tumor_latency | 1.22381293 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.17039001 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15788178 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.15364688 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.14915689 |
| 47 | MP0000598_abnormal_liver_morphology | 1.14395445 |
| 48 | MP0005647_abnormal_sex_gland | 1.14149628 |
| 49 | MP0002896_abnormal_bone_mineralization | 1.13195095 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.11403013 |
| 51 | MP0003186_abnormal_redox_activity | 1.10240302 |
| 52 | MP0008004_abnormal_stomach_pH | 1.10178845 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.09733224 |
| 54 | MP0003984_embryonic_growth_retardation | 1.09433197 |
| 55 | MP0005451_abnormal_body_composition | 1.09247117 |
| 56 | MP0001672_abnormal_embryogenesis/_devel | 1.09011234 |
| 57 | MP0005380_embryogenesis_phenotype | 1.09011234 |
| 58 | MP0000003_abnormal_adipose_tissue | 1.08421698 |
| 59 | MP0002088_abnormal_embryonic_growth/wei | 1.06712166 |
| 60 | MP0000767_abnormal_smooth_muscle | 1.06558101 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.01519641 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 1.01491367 |
| 63 | MP0005621_abnormal_cell_physiology | 1.01426776 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01373456 |
| 65 | MP0003693_abnormal_embryo_hatching | 0.97733719 |
| 66 | MP0009764_decreased_sensitivity_to | 0.96460418 |
| 67 | MP0001216_abnormal_epidermal_layer | 0.96192024 |
| 68 | MP0000350_abnormal_cell_proliferation | 0.95274871 |
| 69 | MP0008057_abnormal_DNA_replication | 0.94794561 |
| 70 | MP0002006_tumorigenesis | 0.94461301 |
| 71 | MP0002166_altered_tumor_susceptibility | 0.93838041 |
| 72 | MP0003279_aneurysm | 0.93548052 |
| 73 | MP0003890_abnormal_embryonic-extraembry | 0.91029969 |
| 74 | MP0001697_abnormal_embryo_size | 0.90784031 |
| 75 | MP0009053_abnormal_anal_canal | 0.90555339 |
| 76 | MP0003111_abnormal_nucleus_morphology | 0.89877008 |
| 77 | MP0005503_abnormal_tendon_morphology | 0.88190137 |
| 78 | MP0002009_preneoplasia | 0.87873017 |
| 79 | MP0005248_abnormal_Harderian_gland | 0.86766741 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 0.85636756 |
| 81 | MP0009763_increased_sensitivity_to | 0.85256583 |
| 82 | MP0003718_maternal_effect | 0.84894743 |
| 83 | MP0005501_abnormal_skin_physiology | 0.83571066 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.83548670 |
| 85 | MP0008932_abnormal_embryonic_tissue | 0.82729790 |
| 86 | MP0005376_homeostasis/metabolism_phenot | 0.80859792 |
| 87 | MP0002060_abnormal_skin_morphology | 0.80240820 |
| 88 | MP0005408_hypopigmentation | 0.78528308 |
| 89 | MP0005395_other_phenotype | 0.77976044 |
| 90 | MP0002254_reproductive_system_inflammat | 0.77636363 |
| 91 | MP0000579_abnormal_nail_morphology | 0.77412158 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.76965707 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.76330396 |
| 94 | MP0002084_abnormal_developmental_patter | 0.76057277 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.75531672 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.74631712 |
| 97 | MP0003077_abnormal_cell_cycle | 0.74171118 |
| 98 | MP0005384_cellular_phenotype | 0.73921402 |
| 99 | MP0008469_abnormal_protein_level | 0.73497382 |
| 100 | MP0001881_abnormal_mammary_gland | 0.73012634 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.72183738 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.72035205 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.71838269 |
| 104 | MP0002080_prenatal_lethality | 0.71821872 |
| 105 | MP0002971_abnormal_brown_adipose | 0.71774971 |
| 106 | MP0004197_abnormal_fetal_growth/weight/ | 0.71340204 |
| 107 | MP0000627_abnormal_mammary_gland | 0.71279884 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.69891481 |
| 109 | MP0001958_emphysema | 0.69860131 |
| 110 | MP0001879_abnormal_lymphatic_vessel | 0.68696739 |
| 111 | MP0003385_abnormal_body_wall | 0.68688966 |
| 112 | MP0000858_altered_metastatic_potential | 0.68659750 |
| 113 | MP0005334_abnormal_fat_pad | 0.67836581 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.66982580 |
| 115 | MP0005266_abnormal_metabolism | 0.66446144 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.66438597 |
| 117 | MP0000377_abnormal_hair_follicle | 0.66267443 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.65940729 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.65802782 |
| 120 | MP0004134_abnormal_chest_morphology | 0.65392152 |
| 121 | MP0002282_abnormal_trachea_morphology | 0.65054615 |
| 122 | MP0003011_delayed_dark_adaptation | 0.63984073 |
| 123 | MP0005448_abnormal_energy_balance | 0.63936655 |
| 124 | MP0005670_abnormal_white_adipose | 0.63504638 |
| 125 | MP0002796_impaired_skin_barrier | 0.62262107 |
| 126 | MP0009278_abnormal_bone_marrow | 0.62199496 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.61198679 |
| 128 | MP0006082_CNS_inflammation | 0.60640932 |
| 129 | MP0001661_extended_life_span | 0.60384796 |
| 130 | MP0003436_decreased_susceptibility_to | 0.60360302 |
| 131 | MP0005636_abnormal_mineral_homeostasis | 0.59463447 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.59105065 |
| 133 | MP0002928_abnormal_bile_duct | 0.57382002 |
| 134 | MP0005023_abnormal_wound_healing | 0.55717872 |
| 135 | MP0002168_other_aberrant_phenotype | 0.55258094 |
| 136 | MP0001756_abnormal_urination | 0.55000166 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.51012055 |
| 138 | MP0009115_abnormal_fat_cell | 0.50892527 |
| 139 | MP0008995_early_reproductive_senescence | 0.49881943 |
| 140 | MP0002249_abnormal_larynx_morphology | 0.49085743 |
| 141 | MP0000566_synostosis | 0.47987406 |
| 142 | MP0001243_abnormal_dermal_layer | 0.45884791 |
| 143 | MP0002933_joint_inflammation | 0.41187588 |
| 144 | MP0001542_abnormal_bone_strength | 0.41089390 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.40738503 |
| 146 | MP0000163_abnormal_cartilage_morphology | 0.40001922 |
| 147 | MP0000538_abnormal_urinary_bladder | 0.39171923 |
| 148 | MP0010030_abnormal_orbit_morphology | 0.38576517 |
| 149 | MP0001340_abnormal_eyelid_morphology | 0.37219877 |
| 150 | MP0010352_gastrointestinal_tract_polyps | 0.37144166 |
| 151 | MP0003953_abnormal_hormone_level | 0.36983362 |
| 152 | MP0002970_abnormal_white_adipose | 0.35250021 |
| 153 | MP0000613_abnormal_salivary_gland | 0.35212688 |
| 154 | MP0005164_abnormal_response_to | 0.34417910 |
| 155 | MP0002115_abnormal_skeleton_extremities | 0.34356306 |
| 156 | MP0000604_amyloidosis | 0.33580870 |
| 157 | MP0003638_abnormal_response/metabolism_ | 0.33569403 |
| 158 | MP0003943_abnormal_hepatobiliary_system | 0.33154935 |
| 159 | MP0001915_intracranial_hemorrhage | 0.32739194 |
| 160 | MP0000371_diluted_coat_color | 0.32495169 |
| 161 | MP0000462_abnormal_digestive_system | 0.32266971 |
| 162 | MP0001845_abnormal_inflammatory_respons | 0.32254355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.89156317 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 6.43269883 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.39154717 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.99095050 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.93590102 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.90579655 |
| 7 | Xanthomatosis (HP:0000991) | 5.63579576 |
| 8 | Hypolipoproteinemia (HP:0010981) | 4.68378402 |
| 9 | Complement deficiency (HP:0004431) | 4.51104704 |
| 10 | Fat malabsorption (HP:0002630) | 4.46277287 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 4.37676737 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.30572659 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.30194541 |
| 14 | Premature rupture of membranes (HP:0001788) | 4.23313996 |
| 15 | Epidermoid cyst (HP:0200040) | 4.22091121 |
| 16 | Hypoglycemic coma (HP:0001325) | 4.20192748 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.19102854 |
| 18 | Joint hemorrhage (HP:0005261) | 4.16614536 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13935393 |
| 20 | Hypochromic microcytic anemia (HP:0004840) | 3.96566215 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.89726614 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.79996904 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.76605130 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.74714705 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.69696819 |
| 26 | Hyperammonemia (HP:0001987) | 3.63709408 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.60248778 |
| 28 | Protrusio acetabuli (HP:0003179) | 3.52913731 |
| 29 | Myocardial infarction (HP:0001658) | 3.52611718 |
| 30 | Hyperglycinemia (HP:0002154) | 3.46754368 |
| 31 | Abnormality of complement system (HP:0005339) | 3.46100096 |
| 32 | Ketosis (HP:0001946) | 3.45590491 |
| 33 | Hyperglycinuria (HP:0003108) | 3.41131431 |
| 34 | Hypoglycemic seizures (HP:0002173) | 3.32122372 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.24558241 |
| 36 | Steatorrhea (HP:0002570) | 3.19176769 |
| 37 | Papillary thyroid carcinoma (HP:0002895) | 3.13847178 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07119416 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.07119416 |
| 40 | Follicular hyperkeratosis (HP:0007502) | 3.05172944 |
| 41 | Arterial tortuosity (HP:0005116) | 3.03255468 |
| 42 | Vascular tortuosity (HP:0004948) | 2.94696120 |
| 43 | Aortic dissection (HP:0002647) | 2.91152922 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84308181 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.81748074 |
| 46 | Ketoacidosis (HP:0001993) | 2.70617435 |
| 47 | Abnormal tarsal ossification (HP:0008369) | 2.66856384 |
| 48 | Vitreoretinal degeneration (HP:0000655) | 2.65081100 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.60512271 |
| 50 | Wormian bones (HP:0002645) | 2.60076768 |
| 51 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.59678041 |
| 52 | Turricephaly (HP:0000262) | 2.59129470 |
| 53 | Hyperglycemia (HP:0003074) | 2.58990077 |
| 54 | Abnormality of proline metabolism (HP:0010907) | 2.58500815 |
| 55 | Hydroxyprolinuria (HP:0003080) | 2.58500815 |
| 56 | Symptomatic seizures (HP:0011145) | 2.56045426 |
| 57 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51152531 |
| 58 | Asymmetry of the thorax (HP:0001555) | 2.50210593 |
| 59 | Flat acetabular roof (HP:0003180) | 2.49495183 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.49373837 |
| 61 | Alopecia of scalp (HP:0002293) | 2.49049542 |
| 62 | Malnutrition (HP:0004395) | 2.48948059 |
| 63 | Acanthocytosis (HP:0001927) | 2.48068961 |
| 64 | Overlapping toe (HP:0001845) | 2.47276868 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.46337883 |
| 66 | Tetraparesis (HP:0002273) | 2.45237397 |
| 67 | Skin nodule (HP:0200036) | 2.42684513 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.42178515 |
| 69 | Abnormality of carpal bone ossification (HP:0006257) | 2.41334709 |
| 70 | Ankle contracture (HP:0006466) | 2.39696675 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.39242595 |
| 72 | Spontaneous abortion (HP:0005268) | 2.35913560 |
| 73 | Aortic aneurysm (HP:0004942) | 2.34227592 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.33419569 |
| 75 | Abnormal delivery (HP:0001787) | 2.30507104 |
| 76 | Atrophic scars (HP:0001075) | 2.28922788 |
| 77 | Abnormality of the ischium (HP:0003174) | 2.27250958 |
| 78 | Renal cortical cysts (HP:0000803) | 2.27093639 |
| 79 | Vascular calcification (HP:0004934) | 2.24918195 |
| 80 | Enlarged kidneys (HP:0000105) | 2.23048762 |
| 81 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.21552904 |
| 82 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.21552904 |
| 83 | Soft skin (HP:0000977) | 2.20968988 |
| 84 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.20524525 |
| 85 | Hypoplastic ischia (HP:0003175) | 2.18751587 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.18328747 |
| 87 | Cholecystitis (HP:0001082) | 2.18328747 |
| 88 | Mitral valve prolapse (HP:0001634) | 2.17652867 |
| 89 | Dilatation of the ascending aorta (HP:0005111) | 2.14102787 |
| 90 | Ankyloglossia (HP:0010296) | 2.13890120 |
| 91 | Metabolic acidosis (HP:0001942) | 2.11332403 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.11166491 |
| 93 | Proximal tubulopathy (HP:0000114) | 2.10799654 |
| 94 | Delayed CNS myelination (HP:0002188) | 2.10432438 |
| 95 | Glomerulonephritis (HP:0000099) | 2.10068977 |
| 96 | Cupped ribs (HP:0000887) | 2.09754096 |
| 97 | Menorrhagia (HP:0000132) | 2.09392719 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08545982 |
| 99 | Cervical subluxation (HP:0003308) | 2.06638200 |
| 100 | Cortical dysplasia (HP:0002539) | 2.06305882 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.05579377 |
| 102 | Curly hair (HP:0002212) | 2.03674197 |
| 103 | Esophageal varix (HP:0002040) | 2.03670946 |
| 104 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.01742498 |
| 105 | Opisthotonus (HP:0002179) | 1.99803339 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 1.99260537 |
| 107 | Abnormal foot bone ossification (HP:0010675) | 1.98901780 |
| 108 | Osteomalacia (HP:0002749) | 1.98840286 |
| 109 | Neonatal short-limb short stature (HP:0008921) | 1.98585850 |
| 110 | Rickets (HP:0002748) | 1.98253061 |
| 111 | Right ventricular cardiomyopathy (HP:0011663) | 1.98073478 |
| 112 | Blue sclerae (HP:0000592) | 1.97726610 |
| 113 | Abnormality of dentin (HP:0010299) | 1.97251348 |
| 114 | Protuberant abdomen (HP:0001538) | 1.96512036 |
| 115 | Pancreatitis (HP:0001733) | 1.95788376 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 1.95113940 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95113940 |
| 118 | Abnormal ossification of hand bones (HP:0005921) | 1.94582696 |
| 119 | Irritability (HP:0000737) | 1.93976463 |
| 120 | Mitral stenosis (HP:0001718) | 1.93963556 |
| 121 | Lethargy (HP:0001254) | 1.93855482 |
| 122 | Thin bony cortex (HP:0002753) | 1.93648634 |
| 123 | Acute hepatic failure (HP:0006554) | 1.93606890 |
| 124 | Relative macrocephaly (HP:0004482) | 1.93258560 |
| 125 | Thyroid carcinoma (HP:0002890) | 1.92834012 |
| 126 | Spondylolisthesis (HP:0003302) | 1.91156988 |
| 127 | Small epiphyses (HP:0010585) | 1.89308252 |
| 128 | Abnormal hand bone ossification (HP:0010660) | 1.89236358 |
| 129 | Gingival bleeding (HP:0000225) | 1.84649756 |
| 130 | Abnormality of the acetabulum (HP:0003170) | 1.84229909 |
| 131 | Hyperextensible skin (HP:0000974) | 1.84221008 |
| 132 | Generalized aminoaciduria (HP:0002909) | 1.83804280 |
| 133 | Abnormality of oral frenula (HP:0000190) | 1.82822730 |
| 134 | Pustule (HP:0200039) | 1.82810031 |
| 135 | Epiphyseal dysplasia (HP:0002656) | 1.82489453 |
| 136 | Abnormal gallbladder morphology (HP:0012437) | 1.81693247 |
| 137 | Increased mean platelet volume (HP:0011877) | 1.81073178 |
| 138 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.79773119 |
| 139 | Bladder diverticulum (HP:0000015) | 1.78219193 |
| 140 | Syringomyelia (HP:0003396) | 1.78186343 |
| 141 | Spinal cord lesions (HP:0100561) | 1.78186343 |
| 142 | Ileus (HP:0002595) | 1.77266791 |
| 143 | Hypophosphatemic rickets (HP:0004912) | 1.77118490 |
| 144 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76308848 |
| 145 | Dicarboxylic aciduria (HP:0003215) | 1.76308848 |
| 146 | Heterotopia (HP:0002282) | 1.75613126 |
| 147 | Vertebral compression fractures (HP:0002953) | 1.75593022 |
| 148 | Insidious onset (HP:0003587) | 1.75481236 |
| 149 | Termporal pattern (HP:0011008) | 1.75481236 |
| 150 | Sparse lateral eyebrow (HP:0005338) | 1.75302852 |
| 151 | Elevated alkaline phosphatase (HP:0003155) | 1.75201532 |
| 152 | Disproportionate tall stature (HP:0001519) | 1.74658204 |
| 153 | Pigmentary retinal degeneration (HP:0001146) | 1.72674754 |
| 154 | Joint laxity (HP:0001388) | 1.72390693 |
| 155 | Advanced eruption of teeth (HP:0006288) | 1.70080657 |
| 156 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.68923518 |
| 157 | Aneurysm (HP:0002617) | 1.68648696 |
| 158 | Fragile skin (HP:0001030) | 1.68014231 |
| 159 | Abnormality of glycolysis (HP:0004366) | 1.67570764 |
| 160 | Broad palm (HP:0001169) | 1.66963316 |
| 161 | Microglossia (HP:0000171) | 1.65975549 |
| 162 | Coarse hair (HP:0002208) | 1.64516917 |
| 163 | Deep philtrum (HP:0002002) | 1.64202213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.76510530 |
| 2 | MAPK15 | 3.54322679 |
| 3 | PINK1 | 3.14584195 |
| 4 | BCKDK | 3.13188196 |
| 5 | DDR2 | 2.95516060 |
| 6 | ERN1 | 2.86490658 |
| 7 | SIK1 | 2.76956219 |
| 8 | LATS1 | 2.73932580 |
| 9 | MAP3K6 | 2.65873369 |
| 10 | ICK | 2.57464616 |
| 11 | AKT3 | 2.57053396 |
| 12 | FRK | 2.56344364 |
| 13 | FGFR4 | 2.41603522 |
| 14 | STK38L | 2.39528645 |
| 15 | ERBB4 | 2.15133296 |
| 16 | TAOK3 | 2.09518564 |
| 17 | IRAK3 | 2.07563089 |
| 18 | MAP3K14 | 1.95742580 |
| 19 | CSK | 1.80888170 |
| 20 | KSR2 | 1.80166428 |
| 21 | MAP3K2 | 1.78969780 |
| 22 | MAP3K9 | 1.77683196 |
| 23 | EIF2AK1 | 1.61393026 |
| 24 | TTK | 1.58659682 |
| 25 | SCYL2 | 1.56549003 |
| 26 | PRPF4B | 1.53173326 |
| 27 | MAP3K3 | 1.52287219 |
| 28 | MAP3K11 | 1.52216537 |
| 29 | EEF2K | 1.44402734 |
| 30 | CDK6 | 1.31783940 |
| 31 | YES1 | 1.31398146 |
| 32 | PKN2 | 1.30728551 |
| 33 | STK3 | 1.28284802 |
| 34 | DYRK1B | 1.24880377 |
| 35 | NUAK1 | 1.23185375 |
| 36 | GSK3A | 1.21332356 |
| 37 | EPHA2 | 1.18520411 |
| 38 | ACVR1B | 1.18317219 |
| 39 | RIPK1 | 1.18000277 |
| 40 | MST1R | 1.16947668 |
| 41 | PIK3CG | 1.16594338 |
| 42 | WNK1 | 1.16284809 |
| 43 | MAPK11 | 1.14765372 |
| 44 | PDK2 | 1.14562694 |
| 45 | MAPK7 | 1.14020154 |
| 46 | PIM1 | 1.13655087 |
| 47 | TRPM7 | 1.11963665 |
| 48 | NEK1 | 1.10194707 |
| 49 | EPHA3 | 1.09367627 |
| 50 | SMG1 | 1.07450189 |
| 51 | FGFR1 | 1.07323667 |
| 52 | PDGFRB | 1.07012870 |
| 53 | BMX | 1.03856629 |
| 54 | PIM2 | 1.03321253 |
| 55 | CHUK | 1.02571152 |
| 56 | KSR1 | 1.01753311 |
| 57 | NLK | 0.98477348 |
| 58 | ZAK | 0.98101214 |
| 59 | TYK2 | 0.94964336 |
| 60 | PRKAA2 | 0.94217273 |
| 61 | CLK1 | 0.94143719 |
| 62 | CDK9 | 0.93709009 |
| 63 | MATK | 0.90328560 |
| 64 | PDGFRA | 0.89931982 |
| 65 | NEK9 | 0.88588733 |
| 66 | CAMK1G | 0.86976624 |
| 67 | SIK3 | 0.84763748 |
| 68 | BRSK2 | 0.84534555 |
| 69 | CDK12 | 0.84522582 |
| 70 | PRKAA1 | 0.83580024 |
| 71 | MTOR | 0.79540450 |
| 72 | TGFBR2 | 0.78228400 |
| 73 | MAP3K13 | 0.77796191 |
| 74 | PIK3CA | 0.76240167 |
| 75 | LATS2 | 0.75703267 |
| 76 | PAK2 | 0.75271994 |
| 77 | MAP3K8 | 0.75157917 |
| 78 | TSSK6 | 0.72727882 |
| 79 | STK39 | 0.72472477 |
| 80 | TAOK2 | 0.72366637 |
| 81 | ABL2 | 0.70497504 |
| 82 | IKBKB | 0.69675900 |
| 83 | MST4 | 0.68870893 |
| 84 | JAK1 | 0.68202855 |
| 85 | GRK1 | 0.68025339 |
| 86 | MET | 0.67849937 |
| 87 | NEK6 | 0.66888449 |
| 88 | ERBB2 | 0.66792329 |
| 89 | PRKD2 | 0.66335003 |
| 90 | JAK2 | 0.65356745 |
| 91 | FLT3 | 0.65226873 |
| 92 | CDK7 | 0.65115171 |
| 93 | RET | 0.64881289 |
| 94 | TRIB3 | 0.63328088 |
| 95 | LMTK2 | 0.63036635 |
| 96 | PLK4 | 0.62390220 |
| 97 | PTK2 | 0.62050863 |
| 98 | PTK6 | 0.61956218 |
| 99 | RAF1 | 0.61796083 |
| 100 | FGR | 0.61766166 |
| 101 | PAK4 | 0.61656732 |
| 102 | BRAF | 0.59977654 |
| 103 | BRD4 | 0.57927804 |
| 104 | MAPK4 | 0.57212885 |
| 105 | FER | 0.55394509 |
| 106 | BMPR2 | 0.54976101 |
| 107 | ARAF | 0.53853493 |
| 108 | FGFR3 | 0.52223009 |
| 109 | RPS6KC1 | 0.51923253 |
| 110 | RPS6KL1 | 0.51923253 |
| 111 | TYRO3 | 0.51407952 |
| 112 | RPS6KB1 | 0.51097017 |
| 113 | MAP3K5 | 0.49966139 |
| 114 | PRKCZ | 0.49754987 |
| 115 | CAMK1D | 0.49417976 |
| 116 | RPS6KA6 | 0.48794416 |
| 117 | MAP3K12 | 0.48667457 |
| 118 | EIF2AK3 | 0.47134836 |
| 119 | SRPK1 | 0.46976809 |
| 120 | TAF1 | 0.46971043 |
| 121 | MAPK3 | 0.46842984 |
| 122 | CHEK1 | 0.46365954 |
| 123 | SGK3 | 0.46007499 |
| 124 | ERBB3 | 0.44905248 |
| 125 | AKT2 | 0.44880866 |
| 126 | EIF2AK2 | 0.44817360 |
| 127 | STK24 | 0.44634301 |
| 128 | IRAK1 | 0.44220053 |
| 129 | CDK8 | 0.43958715 |
| 130 | ABL1 | 0.43240014 |
| 131 | PLK3 | 0.43094863 |
| 132 | SGK2 | 0.43041376 |
| 133 | CDC42BPA | 0.42618432 |
| 134 | TBK1 | 0.42046507 |
| 135 | EPHB1 | 0.41669090 |
| 136 | MELK | 0.41076008 |
| 137 | PRKACG | 0.40839950 |
| 138 | IRAK4 | 0.40648919 |
| 139 | BCR | 0.40633664 |
| 140 | EGFR | 0.40396133 |
| 141 | MAPK1 | 0.39487576 |
| 142 | FGFR2 | 0.38065168 |
| 143 | PRKG2 | 0.36225191 |
| 144 | MAP3K1 | 0.35996620 |
| 145 | MAP2K4 | 0.35306774 |
| 146 | MAP3K10 | 0.33195793 |
| 147 | TTN | 0.32583959 |
| 148 | ATM | 0.32459003 |
| 149 | PBK | 0.32237856 |
| 150 | JAK3 | 0.30784799 |
| 151 | TXK | 0.30590726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.22855619 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30115669 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94466561 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.91762745 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75492524 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74274677 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.67922022 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57582570 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40687211 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34017219 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20140044 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17100597 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12123503 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.10679259 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07442629 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.99665793 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99116054 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89244206 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.89223569 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88888563 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85031022 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84599316 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84157194 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77992264 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74628400 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70569337 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.69857657 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69828377 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.69431710 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67863374 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66822965 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66416632 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64804649 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61472230 |
| 35 | Thyroid cancer_Homo sapiens_hsa05216 | 1.59456592 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59318061 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.53107649 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50029817 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47731483 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.46629814 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.38731876 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38480798 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.32853259 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31714152 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.30483782 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.29337798 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28724172 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27986112 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27895587 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.27734609 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.27711934 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.27492335 |
| 53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27229998 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26488513 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26302365 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18754419 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17586583 |
| 58 | Prostate cancer_Homo sapiens_hsa05215 | 1.17339092 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14309004 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 1.13948954 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10568460 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10429619 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 1.07592162 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 1.05375782 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04621972 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03544902 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00020565 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99944599 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98925702 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98297416 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97317622 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96315313 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96199596 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94917457 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92559827 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90599141 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.89855463 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81751612 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81144050 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80691309 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79812879 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78792281 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75743231 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74450744 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72437762 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72200714 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70109194 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.69934751 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.68296910 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66112744 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65869152 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65489483 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65140211 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64254654 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.62826331 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62527982 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61448007 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59816541 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57930507 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56718723 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54953854 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54798080 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54092221 |
| 104 | Melanoma_Homo sapiens_hsa05218 | 0.52197104 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48962573 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48839621 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48023284 |
| 108 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46099191 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.46005583 |
| 110 | Measles_Homo sapiens_hsa05162 | 0.45096969 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44584732 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44374519 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43624910 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32024510 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.28087679 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27153435 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.25778003 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25038782 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23732581 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23040433 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20720227 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.17979117 |
| 123 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16808461 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.16182531 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.10275861 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09048229 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07937259 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07848978 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06542430 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.06155278 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04952385 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03136538 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02666583 |
| 134 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.01130468 |
| 135 | Hepatitis C_Homo sapiens_hsa05160 | -0.0921971 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0894630 |
| 137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0885917 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0860997 |
| 139 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | -0.0820663 |
| 140 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0761109 |
| 141 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0404579 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0301405 |
| 143 | Protein export_Homo sapiens_hsa03060 | -0.0184621 |
| 144 | Legionellosis_Homo sapiens_hsa05134 | -0.0168775 |
| 145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0080948 |

